"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A.

In order to one day eliminate cervical cancer, the World Health Organization has set out a global strategy: 90 percent of girls to be vaccinated by the age of 15; 70 percent of women screened by the ...

This interesting study presents valuable information on how human cytomegalovirus (HCMV) infection disrupts the activity of the TEAD1 transcription factor, leading to widespread chromatin alterations.

This study found a steep decline in cervical cancer mortality among U.S. women younger than 25 years between 2016 and 2021. This cohort of women is the first to be widely protected against cervical ...

A new study shows a steep drop in cervical cancer deaths among the first cohort of women who were eligible for the HPV vaccine.

This study found a steep decline in cervical cancer mortality among U.S. women younger than 25 years between 2016 and 2021. This ...

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...

Vaccination of 27- to 45-year-olds ("mid-adults") against human papillomavirus (HPV) is less cost-effective than vacc ...

The cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improve when ...

Recently, the number of patients with cervical cancer has been decreasing due to the activation of national checkups and ...

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...